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1  Introduction
Mammalian cell culture titers and cell densities have been
increasing over the years driven by product demand, cost
efficiency targets, and production facility constraints. Cell
culture titers have been reported to have reached >13 g/L
in fed-batch cultures [1], with cell densities beyond
20 × 106 cells/mL [2]. These rises have contributed to an
increase in pressure on primary recovery and purification
operations, which have to adapt to changes in the feed
stream. Although research into alternative downstream
technology options has been carried out over the years [3],
there has been little focus on how to generate representa-
tive feed materials for experimentation.
The key variables, which define the properties of feeds
to primary recovery operations tend to be specific to the
operation in question. However, most published studies
have historically included factors such as solids load [4],
cell density and cell viability [5], and more specifically par-
ticle size distribution [6]. The impact of primary recovery
and purification operations on product recovery as well as
DNA and host cell protein (HCP) impurity removal have
been discussed [2], most often in the context of cell line
and cell culture conditions [7].
Research focused on increasing the understanding of
primary recovery technologies such as centrifugation
[8, 9], depth filtration [10, 11], and tangential flow filtration
(TFF) options [12], have typically used cell culture materi-
al harvested directly from bioreactors. In these cases har-
vest conditions have been stated, such as day of harvest,
cell density at harvest or viability at harvest, but little evi-
dence of control over these feedstream conditions are
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shown. Some studies have focused on just one of the vari-
ables, for example cell viability, and had material harvest-
ed at different days from the cell culture bioreactor to
obtain feed material with varying levels of viability [6].
However, adopting such a methodology can make it diffi-
cult to contextualize the results when relating to other cell
lines or cell culture processes. For example at identical
cell culture days different cell lines or processes can yield
a range of viabilities. In addition unique cell death path-
ways can result in differing particle size distributions
being passed onto the primary recovery operations [13].
Spiking of impurities as well as product has also been
used in the past to mimic different levels of impurity loads
[14, 15] or to provide a measurable concentration, which
can be quantified prior to and post-technology or condi-
tion implementation. However, the stability of the spiked
material in solution must be verified to ensure the spiked
material can be accurately quantified.
Comparing the cell culture material produced using
different cell lines for primary recovery studies and purifi-
cation has also been previously shown [2, 5]. However,
this method can have limitations when deriving correla-
tions or empirical models, as potential biological expres-
sion differences can create a large set of unknowns, espe-
cially where HCP profile differences are significant.
The level of control required to achieve specific prop-
erties in cell culture feeds to downstream operations can
cause considerable strain on the cell culture material gen-
eration even prior to the material reaching primary recov-
ery stages. Other variables can also contribute to the
number of unknowns which in turn could potentially
affect the downstream experimentation including cell
culture scale and scale up methodology, feeding strate-
gies, and metabolite profiles during processing.
This article describes a novel methodology for the con-
sistent creation of materials with a defined set of process-
relevant characteristics and is aimed at producing materi-
al for primary recovery studies. The approach is to control
tightly key cell culture variables and to ensure they are
maintained independently so as to decouple effects from
one another. Such an approach is difficult to achieve when
using cell culture material sourced directly from a cell
 culture operation. The methodology aims to increase the
level of information, which can then be derived from car-
rying out primary recovery and purification studies and to
provide a new avenue for deriving empirical performance
correlations for novel processing technologies, in particu-
lar those designed to handle high cell density feeds.
2  Materials and methods
2.1  Cell culture 5-L scale
Cell culture material was generated using an IgG4 pro-
ducing cell line (CY01) kindly provided by Lonza Biologics
(GB-Slough, Berkshire, UK) in a 5-L (3.5-L working vol-
ume) bioreactor with a stirred tank reactor (STR) with an
in-built control system (B. Braun BIOSTAT B-DCU control
unit, Sartorius, Epsom, UK). Set points were maintained
at 30% air dissolved oxygen tension (DO), 7.10 pH and a
temperature of 37°C. A constant gas flowrate of
100 cm3/min was maintained using a horseshoe sparger.
Agitation was set at 260 RPM using a single 45° pitch,
three-blade impeller. All cell cultures were carried out in
fed-batch mode using chemically defined medium
(CDCHO, Invitrogen, Paisley, UK). The glucose concentra-
tion was measured daily with a NOVA Bioanalyser (Nova
Biomedical, Deeside, UK) and maintained at a concentra-
tion of 2 g/L using a bolus feed of ten-fold concentrated
dry powder CD CHO media, adjusted to a concentration
of 150 g/L glucose (Sigma, Poole, Dorset, UK).
2.2  Cell culture 70-L scale
The CY01 cell line was also used to produce material 
at the 70-L scale using a single-use bioreactor (SUB)
 (BIOSTAT CultiBag STR, Sartorius, UK). Set points were
maintained at 30% dissolved oxygen and a pH of 7.1 at
37°C. Agitation rate was set at 150  RPM. Cell culture
media and feeding strategy were matched to the 5-L STR
conditions.
2.3  Shear study comparison
Cell culture material was harvested at the 5-L scale once
the viability had reached approximately 75%. The materi-
al was loaded into a rotating shear device [4, 6, 9, 16]. High
and low shear (equivalent to maximum energy dissipation
rates of 0.37  ×  106 and 0.019  ×  106 W/kg, respectively)
were applied to the material, with each condition exam-
ined in triplicate. Particle size distributions obtained pre-
and post-exposure to high and low shear of each material
batch were normalized and compared.
2.4  Cell culture harvest
All 5-L STR harvests were performed on days 13–14 of cul-
ture, once the viability had declined to ∼70%. The 70-L
STR harvests were performed daily between day 7 and
day 14 of culture, where 3L of cell culture material was
removed per daily harvest.
2.5  Induced cell apoptosis
On day 13 of the cell cultures, approximately 300 mL of cell
culture material was removed from the 5-L STR, aliquoted
into 50-mL falcon tubes and washed with a sterile phos-
phate buffered saline solution (PBS, Sigma–Aldrich,
Gillingham, Dorset, UK). The sedimented cells were then
incubated on ice for 2 h, then maintained at 37°C for up to
24 h prior to use. Samples were monitored in the first 6 h
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post-apoptosis induction by staining using the Annexin
V-FITC/7ADD kit PN IM3546 (Beckman Coulter, High
Wycombe, UK) and processed using a Coulter Epics XL-
MCL Flow Cytometer (Beckman Coulter, High Wycombe,
UK). Apoptosis data were collected and analyzed using
EXPO 32 ADC XL Color software (Beckman Coulter, High
Wycombe, UK). Samples were analyzed using 488  nm
excitation and detected using 525 and 675 nm band-pass
filters for Annexin V and 7-ADD (7-amino-actynomycin D),
respectively, and collected for 300 s (10 000 events). On
the day of harvest the required volume of the dead cell
stock was calculated based on cell density and viability
measurements of both the harvest material and the dead
cell stock, obtained using a ViCell™ (Invitrogen, Paisley,
UK).
2.6  Cell concentration
Cell culture material was concentrated post-harvest,
using an Asahi Kasei Bio-Optimal MF SL™ module, area
0.005  m2 (Asahi Kasei Medical Co., Tokyo, Japan). The
module was run in TFF mode using the AKTA crossflow
system (GE Healthcare, Little Chalfort, UK) as well as a
manually controlled peristaltic pump for permeate flow
control. The feed was circulated at 240 mL/min and per-
meate was collected at a constant flowrate of 3.5 mL/min,
until the target concentration factor was achieved. The
starting and final concentration volumes (VS and VC,
respectively, in Eqs. 1 and 2) were calculated based on the
starting (DS) and desired (DR) cell densities, as well as the
spike volumes of the product (IgGSP and impurity spikes
(HCPSP, DNASP) and the dead cell stock spike (DCSP)
required.
(1)
(2)
2.7  Impurity and product concentration
Fully purified IgG1 and flowthrough fraction post-protein
A chromatography was kindly provided by Lonza Biolog-
ics. The flowthrough fraction was used to produce the
HCP spike stock solution while the fully purified IgG1 was
used to create the product stock solution. Both the HCP
and IgG1 fractions were concentrated to approximately
50 g/L using a Vivaspin® 20 (Sartorius, UK) with 5000 and
50 000 MWCO filters, respectively. Post-treatment con-
centrations of the HCP stock were confirmed using the
BCA assay (Fisher Scientific, Loughborough, UK). The
IgG1 was quantified by measuring absorbance at 280 nm.
V
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2.8  Analytical techniques
2.8.1  Cell density and viability measurements
Cell culture density and viability were determined using
the ViCellTM (Beckman Coulter, High Wycombe, UK).
Consistency in cell density measurements is dependent
on the dilution required prior to the measurement. Cell
density replicates were typically within ±4 × 106 cells/mL,
however at higher cell densities standard deviations were
up to 10  ×  106 cells/mL due to higher dilution factor
requirements.
2.8.2  Particle size distribution
Particle size distribution measurements were obtained
using the CASY™ (Innovatis, Bielefeld, Germany) analyz-
er. A 150 μm sized orifice was used, providing a measured
particle size range of 0.2–40 μm. Average measurements
of the mean particle size (solids volume basis) were used,
reported from five analyzer measurements. Any readings
with deviations of ≥5% were discarded. The particle sizes
were converted into volume percent relative to the sum of
the detected solids volume material, assuming all of the
particles were spherical. This accounted for differences in
cell density between the samples included in the com-
parison, thereby providing a more reliable representation
of cell robustness. Cumulative percentage volume was
also calculated in order to compare shear effects.
2.8.3  Impurity removal and product yield
DNA and HCP impurities were quantified post the impu-
rity concentration stage as well as in feed samples and
post-primary recovery stages. The DNA concentration
was determined using a Quant-iT™ PicoGreen® dsDNA
Reagent Kit (Invitrogen, Paisley, UK). Due to the high
impurity concentrations present in the cell culture test
material (CCTM) it was necessary to dilute up to 500 times
in order to achieve acceptable readings. In this case the
BCA assay (Fisher Scientific, Loughborough, UK) was
found to be the most consistent for quantifying relative
HCP removal achieved by the various technologies exam-
ined. The HCP concentrations were calculated using the
following equation:
(3)
where TP is the total protein concentration (μg/mL) and
TY is the total product concentration in the sample
(μg/mL). IgG1 concentration was determined using a
HiTrap™ Protein G column (GE Healthcare, UK) run on an
HPLC system (Agilent Technologies, UK). 100 μL of sam-
ple was loaded at <2 g/L at a flowrate of 2 mL/min and
eluted at pH 2.8. Detection was carried out at 220 and
280 nm and replicates were typically within 0.1 g/L.
=[HCP] [TP]- [TY]
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2.8.4  Reducing 2D-PAGE
The concentrated cell culture mimic feed samples pre and
post primary recovery were treated using a 2D Clean-Up
Kit (GE Healthcare) prior to loading 200  μg of protein
resuspended in 125 μg of 7.0 M urea/2.0 M thiourea/4%
CHAPS w/v/0.5% carrier ampholyte/0.002% bromophenol
blue/40 mM DTT, onto a 7 cm IPGPhor strip holder. The
first dimension was then run using a 7 cm IPGPhor strip
(pH3-10 Non-Linear, GE Healthcare, UK). Isoelectric
focusing was performed using the following settings: con-
trolled temperature at 20°C; ≤50 μA/strip; step 1, step-n-
hold at 30 V for 12 h; step 2, gradient at 200 V for 45 min;
step 3, step-n-hold at 500 V for 45 min; step 4, step-n-hold
at 1000  V for 45  min; step 5, step-n-hold at 8000  V for
30 min; step 6, step-n-hold at 8000 V until 8000 total volt
hours had been reached. The strips were then immedi-
ately transferred to be run in the second dimension. 
The strips were equilibrated in 5 mL of LD sample buffer
(Invitrogen, Paisley, UK), containing 1% w/v dithiothere-
itol, followed by a further equilibration with 5 mL of LDS
sample buffer containing 2.5% w/v iodoacetamide. The
second dimension was run using 4–20% pre-cast Bis-Tris
gels (7.0 × 7.0 × 0.1 cm3 ZOOM IPG Well) using the X-Cell
SureLock Mini-Gel System (Invitrogen, Paisley, UK). The
gels were run at 200 V, 60 W per gel, 45 min running time,
using 1 × MES SDS running buffer. The gels were stained
using Sypro Ruby™ stain according to the manufacturers
protocol. The gels were then scanned using a Typhoon
9400 laser scanner (GE Healthcare, UK) with a 100 μm
 pixel size and 600 V PMT.
3  Results and discussion
A representative set of mimic feeds to primary recovery,
termed CCTM were generated to create a wide range of
cell culture conditions. The range of conditions generated
addresses currently common cell density ranges as well
as those reported to be high cell density conditions. The
methodology used is summarized in Fig. 1 and involves
harvesting low cell density cell culture material produced
in a stirred tank bioreactor and concentrating it using a
TFF step. An apoptotic cell stock was also created which
may be used as a cell stock to achieve required cell via-
bility conditions. Product and HCP stocks were also cre-
ated by concentrating glutamine synthetase CHO (GS-
CHO) cell line derived IgG1 and impurities. These were
used to achieve target product and impurity concentra-
tions for the selected conditions. The resultant CCTM
were characterized in terms of the key variables of cell cul-
ture materials when used for primary recovery studies.
We analyzed the methodology in terms of significance of
the cell culture broth source i.e., the impact of scale on cell
sensitivity to shear, as well as the CCTM generation tech-
nique and the consistency of the final material.
3.1  Impact of the cell material source
Cell culture material was produced at bench (5-L) and
pilot scales (70-L). Cell growth, viability profiles, and the
average specific productivity during scale up were pre-
dominantly maintained within one standard deviation of
Figure 1. Schematic illustrating the Template methodology used to produce the CCTM, with independent control of cell density, cell viability, HCP, and
IgG1 concentrations. This methodology was used to achieve a range of high cell densities, viabilities, titer, and HCP concentrations by using cell culture
material harvested from an STR at the 5- and 70-L sales at a cell density <10 × 106 cells/mL and a titer of <1 g/L. The cell cultures were harvested and con-
centrated using TFF, to achieve the target CCTM cell density. When required apoptosis induction was used to generate a dead cell stock which when spiked
was able to provide the target viability of the CCTM. HCP and IgG1 originating from the GS-CHO cell line were spiked into the CCTM to achieve the target
impurity and product concentrations.
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the bench scale results (Fig. 2A). Cell shear sensitivity
profiles were compared by subjecting cell culture materi-
al harvested from both the 5-L STR and the 70-L SUB at
equivalent viabilities of ∼75% to conditions of low and
high shear (Fig. 2B–D). Prior to the application of shear
three populations of cellular material could be observed at
both scales. The 0–7 μm region showing small diameter
cell debris, 7–12 μm region showing apoptotic cell popu-
lations and 12–30 μm region showing live cells. As low
shear was applied a shift toward the smaller particle size
was observed, as well as an increase in the apoptotic cell
population. The decrease in cell size as a response to
applied stress conditions has been observed previously [6,
7]. In addition cell damage is expected as shear is applied,
causing some of the cells to burst, and subsequently the
observed shift in cell size. The change in particle size dis-
tribution profiles between no shear and low shear yielded
similar profiles at 5- and 70-L scales.
A decrease in live cell population was observed when
high levels of shear were applied, along with a concomi-
tant increase in apoptotic and cell debris populations. For
the high shear condition, the decrease in the live cell pop-
ulation observed at the 70-L scale was found to be signif-
icantly different to that at the 5-L scale (p = 0.002). The
apoptotic and the debris populations between the scales
were found also to be significantly different (p < 0.0001).
These differences in live, apoptotic and cell debris popu-
lations between the scales likely indicates a higher level
of susceptibility to shear at the 70-L scale. However, the
impact of this difference is not clear and would have to be
addressed on a case-by-case basis. Therefore, it is rec-
ommended that comparability in shear sensitivity be
explored further in those cases where the scale differ-
ences are deemed significant.
3.2  Generation of mimic feed profiles 
to primary recovery
In order to create mimic feed profiles with different cell
densities and viabilities, it was necessary to decouple the
control of these factors. Different viabilities were achieved
through spiking in material from an independently gener-
ated apoptotic cell stock. This section illustrates the capa-
bilities of the proposed method for achieving target con-
ditions. To achieve a reduction in the viability of the mate-
Figure 2. (A) Cell culture growth curves comparing the cell culture growth
profiles achieved at the 5-L and the 70-L scales. Average viable cell density
and cell viability is shown throughout a 14-day culture period at the two
scales. Dotted lines above and below the average lines indicate ±1
 standard deviation of the repeat 5-L cultures and error bars indicate ±1
standard deviation from a single 70-L scale run. (B) Particle size distribu-
tions of cell culture material harvested at 70–75% viability at the 5-L and
the 70-L scales prior to the application of shear.  Average particle size dis-
tributions of each sample were obtained (n = 5). Measurements where
variation was >10% were discarded and the measurement was repeated.
(C) Particle size distributions at the two scales post low shear application
(0.019 ×  106 W/kg). (D) Particle size distributions post high shear applica-
tion (0.37 × 106 W/kg).
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rial generated using the 5-L STRs, apoptosis was induced
in a portion on the cell culture, creating an apoptotic cell
stock. A similar method has been shown previously to
induce apoptosis early in the culture period [17]. A sam-
ple of the cell culture material was removed from each cul-
ture batch prior to harvest and apoptosis induced in these
fractions using cold shock. Apoptosis staining showed a
rapid increase in the dead cell population and a decrease
in the live cell populations over the course of the following
6 h (Fig. 3A). In addition a migration of the early apoptot-
ic population to the late apoptotic was seen after ∼3.5 h,
and subsequent migration of the late apoptotic cell popu-
lation to the dead cell population at ∼6.4 h post-apoptotic
induction (figure not shown). Overall, a decrease to <20%
cell viability was achieved within 7 h of apoptotic induc-
tion.
Independent control of cell density and viability was
demonstrated during the production of the CCTM (Fig. 3B
and C). Batches named X and Y cell culture material
 produced in 5-L STRs were harvested on day 14, at via-
Figure 3. (A) Apoptosis induction during the production 
of a dead cell stock using cold shock is shown. % live and
dead populations were measured using FACS staining
using the Annexin V-FITC/7ADD kit. Comparison of total
cell density (B) and cell viability (C) achieved in two batch-
es of CCTM generated at the 5-L scale at three key stages
of the CCTM methodology. Light grey bars represent
Batch X with targeted low viability (40%), and a high cell
density of 100 × 106 cells/mL and a concentration factor of
∼28. Dark grey bars represent Batch Y with targeted medi-
um viability (60%), and a high cell density cell density of
100 × 106 cells/mL and a concentration factor of ∼15.
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bilities of 65 and 71% and cell densities of 8  ×  106,
8.5 × 106 cells/mL, respectively. Post-processing, cell den-
sities of 100 × 106 cells/mL were achieved for both batch-
es, while simultaneously achieving different target viabil-
ities of 40% for X and 60% for Y. No significant differences
in cell viability beyond that attributed to measurement
variability was observed during these cell concentration
stages.
The generated apoptotic cell stock was spiked into the
concentrated material to achieve the target culture via-
bility levels. Due to the difference in volumetric addition
of the apoptotic cell stock derived solution a calculated
degree of over-concentration was necessary to achieve
the final target cell densities for cultures X and Y of
220 × 106 and 130 × 106 cells/mL, respectively. The degree
of over-concentration included the volume compensation
for the IgG1 and the HCP spike volumes. Sample-to-sam-
ple variation in both cell density and viability measure-
ments of up to 10% were observed. This was considered
to be within the expected measurement variation as dilu-
tions of 50–80 times were required to obtain readings
within the detection range of the ViCell™.
3.3  Consistency of mimic feed profiles 
to primary recovery
The consistency of the CCTM manufacturing methodolo-
gy was found to vary for each of the target variables.
Achieving the target total cell density was found to be rel-
atively reliable, within 10% of the target cell density. Out-
liers observed at the higher target cell densities of
100 × 106 cells/mL (Fig. 4A) were most likely due to the
increase in measurement error when using the ViCell™
for high cell concentrations. Viability showed greater vari-
ability at low levels of target cell viability. As cells begin to
break down, the accuracy of the trypan blue method
decreased, as the apparent total cell count fell. The per-
centage viability figure consequently became less con-
sistent and representative (Fig. 4B). No dead cell stock
addition was required for the 70-L SUB material, as the
cell viability reduced during the cell concentration stage
of the CCTM production. This reduction in viability dur-
ing the concentration step is consistent with the particle
size distribution data (Fig. 2B–D) suggesting that the
material produced at the 5-L scale may be less shear sen-
sitive than that produced at the 70-L scale. In addition, the
70-L scale material was produced during the course of a
cell culture starting from day 7 to day 14. Tait et al. [6] has
previously shown that day 5–7 cell culture is more sus-
ceptible to shear damage and for the susceptibility
decreases in the following days. Apoptotic and non-viable
cells have been theorized to be more robust due to the
increased porosity of the cell membrane. As a result of this
reduction limited the viability possible to achieve post-
concentration, as the final viabilities were below the tar-
get by 15–20%. HCP and titer concentrations were
increasingly variable as the target concentrations
increased (Fig. 4C and D). This is also likely to be due to
the increase in dilution factors required to quantify effec-
tively the HCP and the IgG1 concentrations once titer
exceeds 10  g/L. The HCP spike consistency was also
observed to be consistent. The total HCP concentration
was kept within 10% batch-to-batch variation.
IgG1 and HCP profiles were also compared in these
three CCTM material batches (Fig. 4Ei–Eiii). IgG1 and
HCPs across the molecular weight and pI spectrum were
shown to be present in the HCP stock. Some level of
inconsistency in the individual isoform volumes were
observed, but the overall diversity in the HCP population
between the three batches was consistent. By adoption of
these methods it was possible to expose the subsequent
processing technologies to a consistent IgG1 and HCP
population within the feed material.
It has been shown previously that toward the end of
the culture period mammalian cell culture material typi-
cally contains three distinct populations within the parti-
cle size distribution: live cell, apoptotic cell, and debris
populations [6]. Consistency in particle size distributions
of the final CCTM material as well as the HCP population
was compared to ensure that the material is to an extent
representative of true cell culture material (Fig. 4Fi–Fiii).
In terms of particle size distribution, three populations
were observed across the three CCTM batches tested.
The large peak at >10 μm includes the majority of live
cells, the smaller population between 5 and 10 μm in par-
ticle size represents the apoptotic cell population and the
low volume fraction population with a particle size of
<5 μm represents cell debris. However, particles <3 μm
were below the detection limit of the instrument, there-
fore have not been quantified. All three populations are
present in the particle size distribution, which is also
present in a typical cell culture material originating in an
STR. Therefore, the CCTM methodology provided a con-
sistent and representative feed material input to primary
recovery operations in terms of particle size distribution.
4  Concluding remarks
This paper sets out to develop and demonstrate an exper-
imental methodology for the creation of a mammalian
CCTM. Cell density, cell viability, product, and impurity
concentrations were manipulated to achieve a range of
cell culture test conditions to provide a controlled set of
key variables in the cell culture feed to primary recovery.
Generation of CCTM material at selected worst case as
well as a range of conditions was shown successfully. Key
cell culture parameters including cell density, cell viabili-
ty, product, and HCP concentrations were successfully
decoupled. An apoptosis induction by cold shock method
was applied to create an apoptotic cell population, which
was used to reduce the viability to the selected target
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Figure 4. Box plots showing the range in achieved conditions versus the target value for the CCTM. Three target combinations of (A) cell density,
(n = 8–10), (B) viability, (n = 8–10), (C) HCP concentration (n = 5–8), and (D) titer (n = 5) were tested. These were manufactured using cell culture material
generated at 70-L scale. The box represents the 25th hand the 75th percentiles, the median is indicated with a black line, the mean with the star. The
whiskers represent data within 1.5 of the interquartile range. (E) Comparison of CCTM profiles generated using culture material from three 5-L STR cul-
tures in terms of (Ei–Eiii): HCP profiles, including the IgG1 product and (Fi–Fiii): equivalent particle size distributions, where % volume fraction of the solids
was calculated based on an average measurement of five repeat samples.
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conditions. The method was applied to cell culture mate-
rial originating from bench and pilot scales. Data showed
that the accuracy of the target conditions achieved using
this method decreased as increasing target concentra-
tions were set. It is likely that this feature is, to an extent,
an artifact of some of the analytical techniques applied
when assaying very high concentrations. The CCTM
methodology, created in this work, was able to preserve
the expected three distinct particle size populations for
live, apoptotic and debris cells with a low batch-to-batch
variation. In addition, the selected HCP stock was found
to provide a wide variety of HCPs varying in molecular
weight and pI, thus providing a basis for determining spe-
cific HCP removal capability of a particular unit operation
during CCTM application.
Overall, the CCTM method was found to decouple the
selected variables in the cell culture feed from down-
stream operations, while providing consistent material
that is representative of typical cell culture material in
terms its key features such as particle size distribution
and HCP population. These features make this methodol-
ogy suitable for application in primary recovery and purifi-
cation unit operation studies.
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